These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18039119)

  • 1. Pathogenesis of nonimmune glomerulopathies.
    Kwoh C; Shannon MB; Miner JH; Shaw A
    Annu Rev Pathol; 2006; 1():349-74. PubMed ID: 18039119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spectrum of focal segmental glomerulosclerosis: new insights.
    D'Agati VD
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):271-81. PubMed ID: 18408478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic role of TGF-β in the progression of podocyte diseases.
    Lee HS
    Histol Histopathol; 2011 Jan; 26(1):107-16. PubMed ID: 21117032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of podocyte injury in chronic kidney disease].
    Asanuma K
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
    Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
    Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting podocyte-associated diseases.
    Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Structure and function of the glomerular filtration barrier].
    Musiał K; Zwolińska D
    Pol Merkur Lekarski; 2005 Mar; 18(105):317-20. PubMed ID: 15997642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendrin location in podocytes is associated with disease progression in animal and human glomerulopathy.
    Asanuma K; Akiba-Takagi M; Kodama F; Asao R; Nagai Y; Lydia A; Fukuda H; Tanaka E; Shibata T; Takahara H; Hidaka T; Asanuma E; Kominami E; Ueno T; Tomino Y
    Am J Nephrol; 2011; 33(6):537-49. PubMed ID: 21606645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
    Lee HS
    Cell Tissue Res; 2012 Jan; 347(1):129-40. PubMed ID: 21541658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal segmental glomerulosclerosis; why does it occur segmentally?
    Nagata M; Kobayashi N; Hara S
    Pflugers Arch; 2017 Aug; 469(7-8):983-988. PubMed ID: 28664408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?
    Voskarides K; Pierides A; Deltas C
    Connect Tissue Res; 2008; 49(3):283-8. PubMed ID: 18661361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.
    Yang Y; Jeanpierre C; Dressler GR; Lacoste M; Niaudet P; Gubler MC
    Am J Pathol; 1999 Jan; 154(1):181-92. PubMed ID: 9916932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour necrosis factor-α drives Alport glomerulosclerosis in mice by promoting podocyte apoptosis.
    Ryu M; Mulay SR; Miosge N; Gross O; Anders HJ
    J Pathol; 2012 Jan; 226(1):120-31. PubMed ID: 21953121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis.
    El-Aouni C; Herbach N; Blattner SM; Henger A; Rastaldi MP; Jarad G; Miner JH; Moeller MJ; St-Arnaud R; Dedhar S; Holzman LB; Wanke R; Kretzler M
    J Am Soc Nephrol; 2006 May; 17(5):1334-44. PubMed ID: 16611717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal segmental glomerulosclerosis: recent advances.
    Pollak MR
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):138-42. PubMed ID: 18277145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The signaling pathways of LMX1B and its role in glomerulosclerosis.
    Zhou TB; Qin YH
    J Recept Signal Transduct Res; 2012 Dec; 32(6):285-9. PubMed ID: 23046462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
    Lee HS; Song CY
    Kidney Blood Press Res; 2010; 33(1):24-9. PubMed ID: 20185928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paracrine role for TGF-β-induced CTGF and VEGF in mesangial matrix expansion in progressive glomerular disease.
    Lee HS
    Histol Histopathol; 2012 Sep; 27(9):1131-41. PubMed ID: 22806900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons from studies on focal segmental glomerulosclerosis: an important role for parietal epithelial cells?
    Smeets B; Dijkman HB; Wetzels JF; Steenbergen EJ
    J Pathol; 2006 Nov; 210(3):263-72. PubMed ID: 16924588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.